Implementation determinants and strategies in integration of PrEP into maternal and child health and family planning services: experiences of frontline healthcare workers in Kenya.
adolescent girls and young women (AGYW)
consolidated framework for implementation research (CFIR)
implementation science
implementation strategies
postpartum
pre-exposure prophylaxis (PrEP)
pregnancy
Journal
Frontiers in reproductive health
ISSN: 2673-3153
Titre abrégé: Front Reprod Health
Pays: Switzerland
ID NLM: 9918230899006676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
04
2023
accepted:
04
09
2023
medline:
6
10
2023
pubmed:
6
10
2023
entrez:
6
10
2023
Statut:
epublish
Résumé
Delivery of PrEP to adolescent girls and young women (AGYW) and to pregnant women through maternal and child health (MCH) and family planning (FP) clinics is scaling up in Kenya. Evaluation of implementation challenges and strategies is critical to optimize delivery. We conducted focus group discussions (FGDs) with healthcare workers (HCWs) in MCH and FP clinics offering PrEP in a large implementation project in Kisumu, Kenya. Discussion guides were based on the Consolidated Framework for Implementation Research (CFIR). FGDs were audio recorded and transcribed. Directed content analysis was used to identify implementation challenges and strategies to overcome them. Fifty HCWs from 26 facilities participated in 8 FGDs. HCWs believed PrEP integration was appropriate because it met the needs of AGYW and pregnant women by providing a female-controlled prevention strategy and aligned with policy priorities of elimination of vertical HIV transmission. They were universally accepting of PrEP provision, especially through MCH clinics, noting the relative advantage of this approach because it: (1) enabled high coverage, (2) harmonized PrEP and MCH visits, and (3) minimized stigma compared to PrEP offered through HIV care clinics. However, HCWs noted implementation challenges affecting feasibility and adoption including: (1) increased workload and documentation burden amid workforce shortages, (2) insufficient health care worker knowledge (3) multiple implementing partners with competing priorities (4) drug and documentation form stockouts. HCWs employed various implementation strategies to overcome challenges, including task shifting from nurses to HIV testing providers, patient flow modifications (e.g., fast-tracking PrEP clients to reduce wait times), PrEP demand generation and myth clarification during health talks, provider education, dedicated PrEP delivery rooms, and coordination with adolescent-friendly services. Additional suggested strategies to improve PrEP integration included community education to increase broader PrEP awareness and enable shorter counseling sessions, and task-shifting data entry and client risk assessments. HCWs were enthusiastic about the appropriateness and acceptability of integrating PrEP services into MCH and FP clinics but noted challenges to adoption and feasibility. Strategies to address challenges focused on improving provider time and space constraints, and increasing provider and client knowledge.
Sections du résumé
Background
UNASSIGNED
Delivery of PrEP to adolescent girls and young women (AGYW) and to pregnant women through maternal and child health (MCH) and family planning (FP) clinics is scaling up in Kenya. Evaluation of implementation challenges and strategies is critical to optimize delivery.
Methods
UNASSIGNED
We conducted focus group discussions (FGDs) with healthcare workers (HCWs) in MCH and FP clinics offering PrEP in a large implementation project in Kisumu, Kenya. Discussion guides were based on the Consolidated Framework for Implementation Research (CFIR). FGDs were audio recorded and transcribed. Directed content analysis was used to identify implementation challenges and strategies to overcome them.
Results
UNASSIGNED
Fifty HCWs from 26 facilities participated in 8 FGDs. HCWs believed PrEP integration was appropriate because it met the needs of AGYW and pregnant women by providing a female-controlled prevention strategy and aligned with policy priorities of elimination of vertical HIV transmission. They were universally accepting of PrEP provision, especially through MCH clinics, noting the relative advantage of this approach because it: (1) enabled high coverage, (2) harmonized PrEP and MCH visits, and (3) minimized stigma compared to PrEP offered through HIV care clinics. However, HCWs noted implementation challenges affecting feasibility and adoption including: (1) increased workload and documentation burden amid workforce shortages, (2) insufficient health care worker knowledge (3) multiple implementing partners with competing priorities (4) drug and documentation form stockouts. HCWs employed various implementation strategies to overcome challenges, including task shifting from nurses to HIV testing providers, patient flow modifications (e.g., fast-tracking PrEP clients to reduce wait times), PrEP demand generation and myth clarification during health talks, provider education, dedicated PrEP delivery rooms, and coordination with adolescent-friendly services. Additional suggested strategies to improve PrEP integration included community education to increase broader PrEP awareness and enable shorter counseling sessions, and task-shifting data entry and client risk assessments.
Conclusions
UNASSIGNED
HCWs were enthusiastic about the appropriateness and acceptability of integrating PrEP services into MCH and FP clinics but noted challenges to adoption and feasibility. Strategies to address challenges focused on improving provider time and space constraints, and increasing provider and client knowledge.
Identifiants
pubmed: 37799494
doi: 10.3389/frph.2023.1205925
pmc: PMC10548203
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1205925Informations de copyright
© 2023 Wagner, Beima-Sofie, Awuor, Owade, Neary, Dettinger, Pintye, Abuna, Lagat, Weiner, Kohler, Kinuthia, John-Stewart and O’Malley.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Lancet HIV. 2020 Jan;7(1):e38-e48
pubmed: 31813837
AIDS. 2017 Oct 23;31(16):2193-2197
pubmed: 28723709
AIDS Behav. 2019 Aug;23(8):2185-2189
pubmed: 30666522
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):417-25
pubmed: 22193774
Implement Sci Commun. 2023 Jul 12;4(1):76
pubmed: 37438779
Front Reprod Health. 2021 May 28;3:668672
pubmed: 36303982
J Int AIDS Soc. 2022 Feb;25(2):e25866
pubmed: 35138678
Lancet HIV. 2020 Aug;7(8):e582-e592
pubmed: 32763221
PLoS Med. 2019 Sep 3;16(9):e1002885
pubmed: 31479452
AIDS Care. 2022 Mar;34(3):363-370
pubmed: 34543077
N Engl J Med. 2016 Feb 25;374(8):761-70
pubmed: 26933850
J Acquir Immune Defic Syndr. 2021 Dec 1;88(4):356-360
pubmed: 34379606
BMJ Sex Reprod Health. 2023 Jul;49(3):210-218
pubmed: 36581443
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219831011
pubmed: 30776954
AIDS Patient Care STDS. 2020 Aug;34(8):336-343
pubmed: 32757980
Implement Sci. 2019 Apr 29;14(1):42
pubmed: 31036028
J Assoc Nurses AIDS Care. 2020 Nov-Dec;31(6):669-677
pubmed: 32675642
PLoS One. 2015 May 05;10(5):e0125525
pubmed: 25942423
J Int AIDS Soc. 2021 Dec;24(12):e25845
pubmed: 34898032
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):590-595
pubmed: 30204720
PLoS Med. 2023 Feb 16;20(2):e1004088
pubmed: 36795763
J Int AIDS Soc. 2020 Jan;23(1):e25426
pubmed: 31912985
J Acquir Immune Defic Syndr. 2022 Jan 1;89(1):34-39
pubmed: 34560769
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221111068
pubmed: 35776525
J Int AIDS Soc. 2023 Feb;26(2):e26061
pubmed: 36807505
BMC Public Health. 2022 Jul 7;22(1):1306
pubmed: 35799121
J Int AIDS Soc. 2019 Sep;22(9):e25378
pubmed: 31498563
Implement Sci Commun. 2023 Aug 14;4(1):93
pubmed: 37580795
PLoS Med. 2016 Sep 27;13(9):e1002133
pubmed: 27676386
PLoS One. 2019 Oct 4;14(10):e0223487
pubmed: 31584987
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
Front Reprod Health. 2023 Jul 06;5:1206150
pubmed: 37484872
AIDS. 2016 Jul 31;30(12):1973-83
pubmed: 27149090